PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
JSPR vs. NGS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between JSPR and NGS is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.0

Performance

JSPR vs. NGS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2025FebruaryMarchApril
-97.48%
92.39%
JSPR
NGS

Key characteristics

Sharpe Ratio

JSPR:

-0.90

NGS:

-0.46

Sortino Ratio

JSPR:

-1.67

NGS:

-0.39

Omega Ratio

JSPR:

0.75

NGS:

0.95

Calmar Ratio

JSPR:

-0.88

NGS:

-0.40

Martin Ratio

JSPR:

-1.81

NGS:

-1.48

Ulcer Index

JSPR:

47.55%

NGS:

15.13%

Daily Std Dev

JSPR:

95.41%

NGS:

48.63%

Max Drawdown

JSPR:

-97.68%

NGS:

-89.59%

Current Drawdown

JSPR:

-97.68%

NGS:

-54.41%

Fundamentals

Market Cap

JSPR:

$57.23M

NGS:

$224.49M

EPS

JSPR:

-$4.89

NGS:

$1.37

Total Revenue (TTM)

JSPR:

$1.17M

NGS:

$119.84M

Gross Profit (TTM)

JSPR:

$288.00K

NGS:

$60.49M

EBITDA (TTM)

JSPR:

$10.83M

NGS:

$48.40M

Returns By Period

In the year-to-date period, JSPR achieves a -82.18% return, which is significantly lower than NGS's -33.02% return.


JSPR

YTD

-82.18%

1M

-29.05%

6M

-76.31%

1Y

-87.08%

5Y*

N/A

10Y*

N/A

NGS

YTD

-33.02%

1M

-17.09%

6M

-11.18%

1Y

-24.01%

5Y*

34.06%

10Y*

-2.16%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

JSPR vs. NGS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR
The Risk-Adjusted Performance Rank of JSPR is 77
Overall Rank
The Sharpe Ratio Rank of JSPR is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of JSPR is 77
Sortino Ratio Rank
The Omega Ratio Rank of JSPR is 55
Omega Ratio Rank
The Calmar Ratio Rank of JSPR is 55
Calmar Ratio Rank
The Martin Ratio Rank of JSPR is 77
Martin Ratio Rank

NGS
The Risk-Adjusted Performance Rank of NGS is 3030
Overall Rank
The Sharpe Ratio Rank of NGS is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of NGS is 3333
Sortino Ratio Rank
The Omega Ratio Rank of NGS is 3434
Omega Ratio Rank
The Calmar Ratio Rank of NGS is 3333
Calmar Ratio Rank
The Martin Ratio Rank of NGS is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

JSPR vs. NGS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for JSPR, currently valued at -0.90, compared to the broader market-2.00-1.000.001.002.00
JSPR: -0.90
NGS: -0.46
The chart of Sortino ratio for JSPR, currently valued at -1.67, compared to the broader market-6.00-4.00-2.000.002.004.00
JSPR: -1.67
NGS: -0.39
The chart of Omega ratio for JSPR, currently valued at 0.75, compared to the broader market0.501.001.502.00
JSPR: 0.75
NGS: 0.95
The chart of Calmar ratio for JSPR, currently valued at -0.88, compared to the broader market0.001.002.003.004.00
JSPR: -0.88
NGS: -0.58
The chart of Martin ratio for JSPR, currently valued at -1.81, compared to the broader market-10.000.0010.0020.00
JSPR: -1.81
NGS: -1.48

The current JSPR Sharpe Ratio is -0.90, which is lower than the NGS Sharpe Ratio of -0.46. The chart below compares the historical Sharpe Ratios of JSPR and NGS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00NovemberDecember2025FebruaryMarchApril
-0.90
-0.46
JSPR
NGS

Dividends

JSPR vs. NGS - Dividend Comparison

Neither JSPR nor NGS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

JSPR vs. NGS - Drawdown Comparison

The maximum JSPR drawdown since its inception was -97.68%, which is greater than NGS's maximum drawdown of -89.59%. Use the drawdown chart below to compare losses from any high point for JSPR and NGS. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-97.68%
-38.84%
JSPR
NGS

Volatility

JSPR vs. NGS - Volatility Comparison

The current volatility for Jasper Therapeutics, Inc. (JSPR) is 16.56%, while Natural Gas Services Group, Inc. (NGS) has a volatility of 21.85%. This indicates that JSPR experiences smaller price fluctuations and is considered to be less risky than NGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%NovemberDecember2025FebruaryMarchApril
16.56%
21.85%
JSPR
NGS

Financials

JSPR vs. NGS - Financials Comparison

This section allows you to compare key financial metrics between Jasper Therapeutics, Inc. and Natural Gas Services Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab